Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation

Abstract

The transcription factor p53 and the cytokine receptor FasL are two of the most famous regulators of cell life, and their alterations can cause a large number of pathologies, including cancer. In this review, we focused on how they can determine defective apoptosis, one of the causes of tumorigenesis and tumor progression. The importance of this knowledge lies in the new perspectives that gene therapy can offer to cure cancer.

Downloads

Download data is not yet available.
Published
2010-01-23
Section
Reviews
Statistics
Abstract views: 241

PDF: 544
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Cappello, F., Bellafiore, M., Palma, A., & Bucchieri, F. (2010). Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation. European Journal of Histochemistry, 46(3), 199-208. https://doi.org/10.4081/1680

Most read articles by the same author(s)